These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10454882)

  • 1. Synthesis, structural studies and pharmacological activity of novel bicyclic compounds derived from 3,4-dihydropyridones: 4-aryl-7,7-dimethyl-2,5-dioxo-1,2,3,4,5,6,7,8-octahydroquinolines.
    Novoa de Armas H; Blaton N; Peeters OM; De Ranter C; Suárez Navarro M; Verdecia Reyes Y; Ochoa Rodriguez E; Morán del Prado L; Martin León N; Quinteiro Fernández M; Seoane Prado C; Soto Cámara JL
    J Pharm Belg; 1999; 54(2):48-50. PubMed ID: 10454882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
    Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
    Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
    Safak C; Sahin I; Sunal R
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, evaluation of the calcium antagonistic activity and biotransformation of hexahydroquinoline and furoquinoline derivatives.
    Simşek R; Safak C; Erol K; Ataman S; Ulgen M; Linden A
    Arzneimittelforschung; 2003; 53(3):159-66. PubMed ID: 12705170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Acetyl-4-aryl-5-oxo-2,7,7-trimethyl-1,4,5,6,7,8-hexahydro-quinoline derivatives and their calcium antagonistic activities.
    Safak C; Ozkanli F; Erol K; Aktan Y
    Arzneimittelforschung; 1995 Nov; 45(11):1154-6. PubMed ID: 8929229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
    Soldatov NM
    Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, evaluation of pharmacological activities and quantitative structure-activity relationship studies of a novel group of bis(4-nitroaryl-1,4-dihyropyridine).
    Miri R; Javidnia K; Hemmateenejad B; Tabarzad M; Jafarpour M
    Chem Biol Drug Des; 2009 Feb; 73(2):225-35. PubMed ID: 19207425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
    Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.
    Zarghi A; Derakhshandeh K; Roshanzamir F; Jorjani M; Rastegar H; Varmazyari M; Shafiee A
    Boll Chim Farm; 2002; 141(1):15-20. PubMed ID: 12064052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of hexahydroquinoline derivatives possessing calcium antagonistic activity.
    Simşek R; Safak C; Erol K; Sirmagül B
    Pharmazie; 2001 Aug; 56(8):665-6. PubMed ID: 11534349
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and calcium antagonistic activity of 2,6,6-trimethyl-3-carbomethoxy(ethoxy)-4-aryl-1,4,5,6,7,8-hexahydroquinoline derivatives.
    Simşek R; Ismailoğlu UB; Safak C; Sahin-Erdemli I
    Farmaco; 2000; 55(11-12):665-8. PubMed ID: 11204940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Budriesi R; Ioan P; Locatelli A; Cosconati S; Leoni A; Ugenti MP; Andreani A; Di Toro R; Bedini A; Spampinato S; Marinelli L; Novellino E; Chiarini A
    J Med Chem; 2008 Mar; 51(6):1592-600. PubMed ID: 18303827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
    Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
    Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR studies in the field of Ca-antagonists: 2-substituted 1,4-dihydropyridines with a xanthone backbone.
    Bisi A; Budriesi R; Chiarini A; Rampa A; Valenti P
    Farmaco; 1993 Nov; 48(11):1491-502. PubMed ID: 8110362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.